Drug Hepatotoxicity, An Issue of Clinics in Liver Disease (Volume 24-1) (The Clinics: Internal Medicine, Volume 24-1)

Name: Drug Hepatotoxicity, An Issue of Clinics in Liver Disease (Volume 24-1) (The Clinics: Internal Medicine, Volume 24-1)
SKU: 135625
Price: 11 USD
Availability: InStock

11 $

Format : Publisher PDF

File Size : 11.4 MB

Category: GASTROENTEROLOGY & HEPATOLOGY BOOKS

Description

Drug Hepatotoxicity, An Issue of Clinics in Liver Disease (Volume 24-1) (The Clinics: Internal Medicine, Volume 24-1)

By Pierre Gholam MD AGAF FAASLD
In collaboration with Consulting Editor, Dr. Norman Gitlin, Dr. Pierre Gholam has put together topics that provide a current clinical update on the treatment and management of patients with drug-induced liver injury (DILI). Expert authors have contributed clinical review articles on the following topics: Epidemiology, Predisposing Factors and Outcomes; Genetic Predisposition to DILI; Causality Assessment Frequent Offenders and Patterns of Injury; Quantitative Systems Toxicology Approaches to Understand and Predict DILI; Liver Histology: Diagnostic and Prognostic Features; Acute Liver Failure Secondary to DILI; DILI in Persons with Pre-existing Chronic Liver Disease; DILI in the Setting of Statin Use; DILI in the Setting of Analgesic Use; DILI Secondary to Herbals and Dietary Supplements; and DILI Reporting and Resources for the Clinician. Readers will come away with the information they need to improve outcomes in patients with DILI.

Introducing the groundbreaking book “Drug-Induced Liver Injury: Diagnosis and Management” by renowned author Dr. Pierre Gholam MD AGAF FAASLD. This comprehensive clinical update provides a wealth of current information on the treatment and management of patients with drug-induced liver injury (DILI). In collaboration with Consulting Editor, Dr. Norman Gitlin, Dr. Gholam has assembled expert authors who contributed their insights and expertise on various essential topics related to DILI.

With drug-induced liver injury being a prevalent concern in the medical field, this book serves as an indispensable resource for healthcare professionals seeking to enhance their understanding of the subject and improve patient outcomes. Readers will gain a deeper insight into the epidemiology, predisposing factors, and outcomes of DILI, along with genetic predisposition to DILI. The book explores the causality assessment, frequent offenders, and patterns of injury, allowing clinicians to make more accurate diagnoses and treatment decisions.

One of the novel aspects of this book is the exploration of quantitative systems toxicology approaches to understand and predict DILI. By leveraging advanced techniques and technologies, healthcare professionals can now gain a clearer understanding of how specific drugs affect the liver, ultimately leading to better patient care. The book also delves into the role of liver histology in diagnosing and prognosticating DILI, providing clinicians with valuable insights into this important aspect of patient management.

Acute liver failure secondary to DILI is a critical concern, and this book covers this topic comprehensively. It also addresses DILI in persons with pre-existing chronic liver disease, a particularly challenging scenario that requires specialized management approaches. The book is valuable not only for general healthcare professionals but also for those dealing with specific scenarios such as DILI in the setting of statin or analgesic use.

Furthermore, the book sheds light on the often-overlooked topic of DILI secondary to herbals and dietary supplements. With the increasing popularity of these products, it is essential for healthcare professionals to recognize and manage potential liver injury resulting from their use. Finally, the book provides clinicians with essential resources for reporting and managing DILI, ensuring that they have the tools and information necessary to provide optimal patient care.

Readers will appreciate the clarity and depth of knowledge provided by the expert authors in this book. The topics are presented in a concise and easy-to-understand manner, making it an accessible resource for healthcare professionals at all levels of expertise. Dr. Pierre Gholam, with his extensive experience and expertise in hepatology, has curated a collection of articles that provide a comprehensive and updated overview of DILI diagnosis and management.

Packed with useful information, “Drug-Induced Liver Injury: Diagnosis and Management” promises to be a valuable asset for healthcare professionals seeking to enhance their understanding of DILI. The book is published by Elsevier, a reputable publisher known for delivering high-quality medical literature. With its first edition released on December 5, 2019, the book offers the latest insights and research on DILI, ensuring that readers have access to the most current information available.

Ordering this book will not only equip healthcare professionals with the knowledge needed to improve clinical outcomes in patients with DILI but will also help foster a deeper understanding of this complex medical condition. By gaining a better grasp of DILI, healthcare professionals can provide more accurate diagnoses, develop effective treatment plans, and improve patient care.

Don’t miss out on the opportunity to enhance your expertise in drug-induced liver injury with this essential resource. Order your copy of “Drug-Induced Liver Injury: Diagnosis and Management” today and take a step towards improving patient care and outcomes.